文献速递肝胆胰外科围术期管理与 ERAS

良性导管内乳头状黏液性肿瘤胰腺切除:友好火力的附带损伤

Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire.
PubMed 文献 · Surgery · 2022-06-03

本研究评估低级别导管内乳头状黏液性肿瘤的手术指征及围术期和长期并发症。2009-2018年间133例患者中,总体手术并发症发生率为55.6%,15.8%出现Clavien-Dindo≥3级并发症,中位随访60个月后11.5%良性复发、1.8%发生胰腺导管腺癌,部分胰腺切除后51.3%需胰酶替代治疗。结论提示术者应权衡肿瘤变性与手术风险。

要点

  • 低级别IPMN切除率从43.6%降至27.8%,但过度治疗风险仍存。
  • 总体并发症55.6%,Clavien-Dindo≥3级占15.8%,90天死亡率1.5%。
  • 部分胰腺切除后51.3%需胰酶替代,非糖尿病者26%新发糖尿病。

核心结论

  • 鉴于胰腺切除的并发症和长期并发症发生率,术者应仔细权衡IPMN变性的真实风险与手术切除风险。

研究设计与样本

  • 回顾性纳入2009-2018年最终组织学为低级别IPMN且接受手术切除的患者,共133例(62例女性,中位年龄68岁)。

主要发现

  • 低级别IPMN切除率从2009-2012年的43.6%降至2013-2018年的27.8%(P = .003)。
  • 总体手术并发症发生率为55.6%,15.8%发生Clavien-Dindo≥3级并发症,再手术率3.8%,90天术后死亡率1.5%。
  • 中位随访60个月后,13例(11.5%)胰腺残端良性IPMN复发,2例(1.8%)发生胰腺导管腺癌。
  • 部分胰腺切除后,51.3%患者接受胰酶替代治疗;非糖尿病者中26%新发糖尿病,其中38%为胰岛素依赖。
  • 18例(13.7%)发生切口疝。

关键数值与推荐

  • 24.1%有1个担忧特征,39.8%有≥2个担忧特征,18.8%有≥1个高危征象,15.8%有≥1个担忧特征+1个高危征象。

临床怎么用

  • 对低级别IPMN患者,术前应综合评估高危征象与担忧特征,并充分告知手术并发症及长期胰酶替代、糖尿病和切口疝风险,避免过度切除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical resection of intraductal papillary mucinous neoplasms is based on preoperative high-risk stigmata/worrisome features, but the risk of overtreatment remains high. The aim of this study was to evaluate surgical indications and perioperative and long-term complications in patients with low-grade intraductal papillary mucinous neoplasms. METHODS: Patients who underwent surgical resection between 2009 and 2018 with a final histology of low-grade intraductal papillary mucinous neoplasms were included. Surgical indications, type of surgery, and short- and long-term outcomes were evaluated. RESULTS: A significant decrease in the rate of patients resected for low-grade intraductal papillary mucinous neoplasms was observed (43.6% in 2009-2012 vs 27.8% in 2013-2018; P = .003), and 133 patients were finally included (62 women, median age: 68 years). Of these, 24.1% had 1 worrisome feature, 39.8% had ≥2 worrisome features, 18.8% had ≥1 high-risk stigmata, and 15.8% had ≥1 worrisome features + 1 high-risk stigmata. Overall surgical morbidity was 55.6%, 15.8% had Clavien-Dindo ≥3 complications, reoperation rate was 3.8%, and 90-day postoperative mortality was 1.5%. After a median follow-up of 60 months, 13 patients (11.5%) had a recurrence of benign intraductal papillary mucinous neoplasm in the pancreatic remnant, and 2 patients (1.8%) developed pancreatic ductal adenocarcinoma. After partial pancreatectomy, 51.3% of patients were taking pancreatic enzyme replacement therapy. Among nondiabetics, 26% developed diabetes after partial pancreatectomy, of which 38% were insulin-dependent. Eighteen patients (13.7%) developed incisional hernia. CONCLUSION: Given the rates of morbidity and long-term complications after pancreatic resections, surgeons should attentively balance the true risks of intraductal papillary mucinous neoplasm degeneration with the risks of surgical resection in each patient.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Aleotti F, Crippa S, Belfiori G, et al. Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire. Surgery. 2022. PMID: 35667898. doi:10.1016/j.surg.2022.04.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。